Houston Texans wide receiver John Metchie III, a 2022 second-round NFL draft pick, announced he’s been diagnosed with acute promyelocytic leukemia (APL) and will likely sit out the entire season.

Metchie III said he is receiving “great medical care” and that APL is the “most curable form of leukemia.”

“My main focus will be on my health and recovery. Thank you in advance for your support and well wishes,” he said via the Texans’ Twitter account Sunday.

Houston selected Metchie III out of Alabama as the 44th overall pick in this year’s draft and eventually agreed to a four-year, $8 million contract with the wideout.

According to the Genetic and Rare Diseases Information Center, APL occurs when “there are too many immature blood-forming cells (promyelocytes) in the blood and bone marrow.” 

The influx of promyelocytes can diminish a person’s blood-cell and platelet counts, while also causing bleeding and blood clots. 

This is a developing story.

Get more from National Football League Follow your favorites to get information about games, news and more.